Healthcare -
Biotechnology - NASDAQ - US
$ 0.62
0.977 %
$ 64.4 M
Market Cap
-1.35
P/E
UNCY - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities UNCY - Unicycive Therapeutics, Inc.
27.5 M
LAST VALUE
10.95%
2 YEAR CAGR
102.94%
5 YEAR CAGR
0.00%
10 YEAR CAGR